Sennosides
- Product NDC
- 69848-016
- 11-digit product format
- 698480016
- Labeler code
- 69848
- Product ID
- 69848-016_468e82c6-8c4a-672c-e063-6394a90a5f0e
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Sennosides
- Dosage form
- CAPSULE, LIQUID FILLED
- Route
- ORAL
- Labeler
- Granules USA Inc
- Application
- M007
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2020-05-29
- Substance
- SENNOSIDES
- Active strength
- 17.2 mg/17.21
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Sennosides
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| SENNOSIDES | 17.2 mg/17.21 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 3FYP5M0IJX | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 2169295 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| a619b8f4-1b5d-181b-e053-2995a90ab729 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| baf7f49c-75b6-496b-a00e-8e766a8e4f03 | Product name | 1 | 20210127 |
| ebc62596-fc97-4d03-9483-7ba095d25db7 | Product name | 1 | 20151210 |
| 0ca1d589-929b-4b33-bc5b-1d84abdafa6a | Product name | 1 | 20150324 |
| fc363c46-397b-4476-ac0f-70e43e8e4592 | Product name | 1 | 20150324 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 69848-016-10 | 2023-03-02 | C162847 | 48780-1 | f386c64a-3279-0266-e053-dadaa90a7c1a | EXTRA STRENGTH Senna Softgels Standerdized Senna Concentrate Sennosides 17.2 mg |
| 69848-016-10 | 2023-01-30 | C162847 | 48780-1 | f386c64a-3279-0266-e053-dadaa90a7c1a | EXTRA STRENGTH Senna Softgels Standerdized Senna Concentrate Sennosides 17.2 mg |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 69848-016-10 | Sennosides | 100 in 1 BOTTLE | CAPSULE, LIQUID FILLED | 100 | 5 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Fleet | BISACODYL | C.B. Fleet Company, Inc. | 324e61eb-8f6b-48d7-85c2-b1b5642691c9 | 2025-06-23 | Warnings | M007 |
| Saline Laxative | SODIUM PHOSPHATE | Walgreen Company | fb260df0-7bda-4299-84a5-44c8f9447798 | 2025-06-18 | Warnings | M007 |
| De La Cruz Castor Oil | CASTOR OIL | DLC Laboratories, Inc. | 22fbad2e-e9fa-46ba-8617-ad79483cbe9a | 2025-06-13 | Warnings | M007 |
| Prolaxa | DOCUSATE SODIUM 250MG | Terrain Pharmaceuticals | 32610e42-f352-09fd-e063-6394a90abff6 | 2025-06-12 | Warnings | M007 |
| DOCUZEN | SENNOSIDES 8.6MG AND DOCUSATE SODIUM 50MG | Village Pharma | 29102014-9b0e-4899-958d-83111f94a612 | 2025-06-01 | Warnings | M007 |
| MILK OF MAGNESIA | MAGNESIUM HYDROXIDE | Power Health, Products, Inc. | 364b558b-69b5-bfa4-e063-6294a90acd0c | 2025-05-29 | Warnings | M007 |
| MILK OF MAGNESIA | MAGNESIUM HYDROXIDE | Power Health, Products, Inc. | 364bc4f5-6337-6c89-e063-6394a90a12ab | 2025-05-29 | Warnings | M007 |
| SENNA | SENNOSIDES | AARNA USA INC. | 364d4dfc-a089-1a27-e063-6394a90ad77b | 2025-05-29 | Warnings | M007 |
| MILK OF MAGNESIA CHERRY | MAGNESIUM HYDROXIDE | Power Health, Products, Inc. | 3634b4e4-4fea-9428-e063-6394a90a6ad9 | 2025-05-28 | Warnings | M007 |
| MILK OF MAGNESIA ORIGINAL | MAGNESIUM HYDROXIDE | ATLANTIC BIOLOGICALS CORP. | 30fb7b5e-56a3-423e-ae57-432006b54fff | 2025-05-23 | Warnings | M007 |
| Senna Liquid | SENNA LIQUID | Belleview Biosciences | 35d5f217-b101-3cd8-e063-6394a90adccd | 2025-05-23 | Warnings | M007 |
| Stool Softener Laxative | DOCUSATE SODIUM | Walgreens | 816c82f8-0fa5-4b22-a226-e8f22f3eaa1d | 2025-05-23 | Warnings | M007 |
| Senna Laxative | SENNA | PD-Rx Pharmaceuticals, Inc. | 2b03d07c-ea4f-4663-bcc3-20ebdf83b7aa | 2025-05-21 | Warnings | M007 |
| Senna | SENNOSIDES | Akron Pharma Inc. | 55ce3969-d7a6-49c4-8c13-d95690efc1a6 | 2025-05-16 | Warnings | M007 |
| Saline Enema | SODIUM PHOSPHATE MONOBASIC, SODIUM PHOSPHATE DIBASIC | Dynarex Corporation | 7c7b68af-4ef2-4f84-9279-9f7a91c8d9c5 | 2025-05-14 | Warnings | M007 |
| Bisacodyl | BISACODYL | Rising Pharma Holdings, Inc. | 03429da4-1ce9-4789-bf54-ce1b3215b013 | 2025-05-13 | Warnings | M007 |
| COLACE EXTRA STRENGTH STOOL SOFTNER | DOCUSATE SODIUM | Atlantis Consumer Healthcare Inc. | 34e06b05-64a5-4b3e-af38-cdcd7c1d521b | 2025-05-01 | Warnings | M007 |
| Senna | SENNOSIDES | PAI Holdings, LLC dba PAI Pharma | 7c28ffb8-149f-4a5a-ab98-dfa7b3b0f6ed | 2025-04-28 | Warnings | M007 |
| Docusate Sodium | DOCUSATE SODIUM | Belleview Bio Science | 335f41d7-5c22-7c17-e063-6294a90a8f28 | 2025-04-22 | Warnings | M007 |
| Docusate Sodium | DOCUSATE SODIUM | American Health Packaging | e5028f6d-d33d-47a9-8453-00af5cdf59a6 | 2025-04-20 | Warnings | M007 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 2169295 | sennosides 17.2 MG Oral Capsule | PSN | a619b8f4-1b5d-181b-e053-2995a90ab729 | 5 |
| 2169295 | sennosides, USP 17.2 MG Oral Capsule | SCD | a619b8f4-1b5d-181b-e053-2995a90ab729 | 5 |
| 2169295 | sennosides 17.2 MG Oral Capsule | SY | a619b8f4-1b5d-181b-e053-2995a90ab729 | 5 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 69848-016-10 | 69848001610 | 100 CAPSULE, LIQUID FILLED in 1 BOTTLE (69848-016-10) | 2020-05-29 | 0000-00-00 | No | No | Current |